References
- Almhdawi KA, Alazrai A, Kanaan S, et al. Post-stroke depression, anxiety, and stress symptoms and their associated factors: a cross-sectional study. Neuropsychol Rehabil. 2020:1–14. doi:https://doi.org/10.1080/09602011.2020.1760893.
- Ayerbe L, Ayis S, Wolfe CDA, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry. 2013;202(1):14–21.doi:https://doi.org/10.1192/bjp.bp.111.107664.
- Medeiros GC, Roy D, Kontos N, Beach SR. Post-stroke depression: a 2020 updated review. Gen Hosp Psychiatry. 2020;66:70–80. doi:https://doi.org/10.1016/j.genhosppsych.2020.06.011.
- Asplund K, Hulter Asberg K, Appelros P, et al. The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke. 2011;6(2):99–108. doi:https://doi.org/10.1111/j.1747-4949.2010.00557.x.
- Clemens S, Begum N, Harper C, Whitty JA, Scuffham PA. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res. 2014;23(8):2375–2381. doi:https://doi.org/10.1007/s11136-014-0676-x.
- Hinz A, Kohlmann T, Stobel-Richter Y, Zenger M, Brahler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443–447. doi:https://doi.org/10.1007/s11136-013-0498-2.
- Konig -H-H, Bernert S, Angermeyer MC, et al. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009;47(2):255–261. doi:https://doi.org/10.1097/MLR.0b013e318184759e.
- McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D–5L: south Australian population norms. Health Qual Life Outcomes. 2016;14(1):133. doi:https://doi.org/10.1186/s12955-016-0537-0.
- Saarni SI, Harkanen T, Sintonen H, et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res. 2006;15(8):1403–1414. doi:https://doi.org/10.1007/s11136-006-0020-1.
- Shiroiwa T, Fukuda T, Ikeda S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25(3):707–719. doi:https://doi.org/10.1007/s11136-015-1108-2.
- Andrew NE, Kilkenny MF, Lannin NA, Cadilhac DA. Is health-related quality of life between 90 and 180 days following stroke associated with long-term unmet needs? Qual Life Res. 2016;25(8):2053–2062. doi:https://doi.org/10.1007/s11136-016-1234-5.
- Jorgensen TS, Turesson C, Kapetanovic M, et al. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: a prospective observational study of patients registered in the south Swedish SSATG registry. PLoS One. 2017;12(2):e0169946. doi:https://doi.org/10.1371/journal.pone.0169946.
- Kim S-H, Jo M-W, Lee J-W, Lee H-J, Kim JK. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea. Health Qual Life Outcomes. 2015;13(1):203. doi:https://doi.org/10.1186/s12955-015-0399-x.
- Chen P, Lin K-C, Liing R-J, Wu C-Y, Chen C-L, Chang K-C. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation. Qual Life Res. 2016;25(6):1585–1596. doi:https://doi.org/10.1007/s11136-015-1196-z.
- Carlson KD, Herdman AO. Understanding the Impact of Convergent Validity on Research Results. Organizational Res Methods. 2012;15(1):17–32. doi:https://doi.org/10.1177/1094428110392383.
- Salinas J, Sprinkhuizen SM, Ackerson T, et al. An International Standard Set of Patient-Centered Outcome Measures After Stroke. Stroke. 2016;47(1):180–186. doi:https://doi.org/10.1161/STROKEAHA.115.010898.
- Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.
- Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as Screening Instruments for Depression in Stroke Patients. Psychosomatics. 2002;43(5):386–393. doi:https://doi.org/10.1176/appi.psy.43.5.386.
- Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res. 2002;52(2):69–77. doi:https://doi.org/10.1016/S0022-3999(01)00296-3.
- Sagen U, Vik TG, Moum T, Mørland T, Finset A, Dammen T. Screening for anxiety and depression after stroke: comparison of the Hospital Anxiety and Depression Scale and the Montgomery and Åsberg Depression Rating Scale. J Psychosom Res. 2009;67(4):325–332. doi:https://doi.org/10.1016/j.jpsychores.2009.03.007.
- Prisnie JC, Fiest KM, Coutts SB, et al. Validating screening tools for depression in stroke and transient ischemic attack patients. Int J Psychiatry Med. 2016;51(3):262–277. doi:https://doi.org/10.1177/0091217416652616.
- Kruithof N, Van Cleef MHM, Rasquin SMC, Bovend’Eerdt TJH. Screening Poststroke Fatigue; Feasibility and Validation of an Instrument for the Screening of Poststroke Fatigue throughout the Rehabilitation Process. J Stroke Cerebrovascular Dis. 2016;25(1):188–196. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.015.
- Trippolini MA, Dijkstra PU, Geertzen JHB, Reneman MF. Construct Validity of Functional Capacity Evaluation in Patients with Whiplash-Associated Disorders. J Occup Rehabil. 2015;25(3):481–492. doi:https://doi.org/10.1007/s10926-014-9555-0.
- Szende A, Devlin N, Oppe M. EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Dordrecht: Springer; 2007.
- Payakachat N, Ali MM, Tilford JM. Can The EQ-5D Detect Meaningful Change? A Systematic Review. PharmacoEconomics. 2015;33(11):1137–1154. doi:https://doi.org/10.1007/s40273-015-0295-6.
- Breen S, Cadilhac DA, Lannin NA, et al. The Australian Stroke Clinical Registry Annual Report 2018. The Florey Institute of Neuroscience and Mental Health; December 2019, Report No 10, p 70.
- Jutte JE, Needham DM, Pfoh ER, Bienvenu OJ. Psychometric evaluation of the Hospital Anxiety and Depression Scale 3 months after acute lung injury. J Crit Care. 2015;30(4):793–798. doi:https://doi.org/10.1016/j.jcrc.2015.04.006.
- Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabetic Med. 2009;26(2):153–161. doi:https://doi.org/10.1111/j.1464-5491.2008.02648.x.
- Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015;13(1):14. doi:https://doi.org/10.1186/s12955-014-0203-3.
- Zou KH, O’Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007;115(5):654–657. doi:https://doi.org/10.1161/CIRCULATIONAHA.105.594929.
- Mandrekar JN. Receiver Operating Characteristic Curve in Diagnostic Test Assessment. J Thoracic Oncol. 2010;5(9):1315–1316.doi:https://doi.org/10.1097/JTO.0b013e3181ec173d.
- Strik JJMH, Honig A, Lousberg R, Denollet J. Sensitivity and Specificity of Observer and Self-Report Questionnaires in Major and Minor Depression Following Myocardial Infarction. Psychosomatics. 2001;42(5):423–428. doi:https://doi.org/10.1176/appi.psy.42.5.423.
- Lutgendorf MA, Stoll KA. Why 99% may not be as good as you think it is: limitations of screening for rare diseases. J Maternal-Fetal Neonatal Med. 2016;29(7):1187–1189.
- Van Der Vliet QMJ, Bhashyam AR, Hietbrink F, Houwert RM, Öner FC, Leenen LPH. Routine incorporation of longer-term patient-reported outcomes into a Dutch trauma registry. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2019;28(10):2731‐9.doi:https://doi.org/10.1007/s11136-019-02211-y.
- Gabbe BJ, McDermott E, Simpson PM, et al. Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population. Popul Health Metr. 2015;13(1). doi:https://doi.org/10.1186/s12963-015-0047-z.
- Hranov LG. Comorbid anxiety and depression: illumination of a controversy. Int J Psychiatry Clin Pract. 2007;11(3):171–189. doi:https://doi.org/10.1080/13651500601127180.
- Golicki D, Niewada M, Buczek J, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–850. doi:https://doi.org/10.1007/s11136-014-0834-1.
- Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717–1727. doi:https://doi.org/10.1007/s11136-012-0322-4.